News Bulletin
Wednesday, August 19, 2026
Evening Edition

Economic Numbers:

Time	Event	Actual	Forecast	Previous
Wednesday, August 19, 2026
10:30	Crude Oil Inventories	4.405M	0.200M	17.423M
10:30	Cushing Crude Oil Inventories	-1.314M		1.611M
13:00	20-Year Bond Auction	5.20%		5.16%
14:00	FOMC Meeting Minutes
14:30	U.S. President Trump Speaks

Indices

	CLOSE	50 DMA	200 DMA
DJIA	53,463.11	52,485.44	49,499.09
NASDAQ	26,331.09	25,923.46	24,218.63
S&P 500	7,708.09	7,528.09	7,086.39

Earnings Calendar:

(EPS: Earning Per Share / Rev: Revenue / Mkt Cap: market Capital/ BMO: Before Market Opening /AMC: After Market Close)

COMPANY	EPS Act	EPS Fore	Rev Act	Rev Fore	Mkt Cap	Time
Analog DevicesADI:US	3.45	3.31	4.02B	3.9B	$197.61B	AM
TJX CompaniesTJX:US	1.22	1.19	15.2B	15.18B	$181.45B	AM
Lowe's CompaniesLOW:US	4.4	4.25	26B	26.27B	$126.48B	AM
TargetTGT:US	4.11	2.26	26.54B	26.03B	$56.48B	AM
Estée LauderEL:US	0.39	0.32	3.63B	3.55B	$29.26B	AM
NordsonNDSN:US	-	3.1	-	779.5M	$15.80B	PM
AimcoAIV:US	-	-	-	-	$6.27B	PM
HUBHUBG:US	-	0.29	-	941.12M	$2.45B
CotyCOTY:US	-	-0.01	-	1.19B	$2.06B	PM
John B Sanfilippo SonJBSS:US	-	1.3	-	271.78M	$889.00M	PM

Market News:

Wall Street on Wednesday ended higher, as a boost from sliding U.S. Treasury yields largely offset weakness in technology stocks. Market participants also received the latest Federal Reserve minutes, which showed many policymakers saw interest rate hikes likely if inflation did not decline.

Marvell Technology advanced on the disclosure of a commercial agreement with Alphabet’s Google to develop custom semiconductor products, but that advance failed to translate to the broader chip space, with the Philadelphia Semiconductor Index falling more than 2%.

The benchmark S&P 500 index climbed 0.2% to close at 7,710.70 points, while the tech-heavy NASDAQ Composite added 0.2% as well to settle at 26,331.09 points. The blue-chip Dow Jones Industrial Average also rose 0.2% to conclude at 53,463.11 points.

U.S. Treasury moves to calm bond markets

The big story in markets continues to be the fixed-income space, which got a major reprieve after the U.S. Department of the Treasury announced it would at least double buyback operations for long-dated bonds, sending the 30-year yield tumbling from nearly two-decade highs.

Effective September 9, liquidity support buyback operations for longer-dated nominal coupon securities (the 10-year to 20-year sector and the 20-year to 30-year sector) will double in size from $2 billion per operation to $4 billion.

"This increase in buyback operation sizes reflects Treasury’s desire to provide greater liquidity support in longer-dated nominal sectors where there is consistent strong sponsorship from market participants, as evidenced by the significant volume of high-quality offers Treasury routinely receives in longer-dated buyback operations," the department said in a statement.

The move led to an immediate reaction across the longer-end U.S. Treasury yield curve, as traders snapped up bonds. The 30-year yield was last down 9.9 basis points to 5.186%, a day after hitting 5.337%, its highest level since June 2007.

Coming into Wednesday, longer-term bonds in particular had been caught up in a sell-off roughly since the Fed’s July interest rate decision, driven by inflation jitters due to rising oil prices and concerns over the massive amount of debt being issued by mega-cap companies to fund their artificial intelligence infrastructure spending. Shorter maturities had fared much better, helped by recent economic data that reduced expectations of imminent Fed rate hikes.

Fed minutes show elevated inflation concerns

Wednesday also saw the release of the minutes of the Fed’s July meeting, which showed many policymakers seeing rate hikes likely if inflation did not decline. The Fed had held rates steady at that meeting, but three regional presidents had dissented with the move.

"In their consideration of monetary policy at this meeting, most participants supported maintaining the current target range for the federal funds rate. Participants generally thought that the information that would accumulate in the intermeeting period could provide more clarity, and correspondingly reduce uncertainty, about the inflation outlook," the minutes said.

Trump again asserts control over the Strait of Hormuz

Turning to the Middle East, oil prices added on to their weekly gains on Wednesday, with Brent crude futures, the global benchmark, last up 0.4% to $91.40 a barrel. The advance came as the U.S. and Iran continued to remain at an impasse over the Strait of Hormuz, with both sides once again independently claiming control of the vital waterway.

President Donald Trump on Tuesday said that no talks with Iran were ongoing or scheduled and that a U.S. naval blockade remained in force, while Tehran denied negotiations.

"We have possession, complete control of the strait," the U.S. leader told reporters on Wednesday. "Maybe at some point," he added, when asked whether Washington and Tehran would restart talks.

Iran has demanded that the U.S. fulfill conditions such as ceasing hostilities across all fronts and unfreezing Iranian assets before the strait can be reopened. Iran has separately been working on a framework for management of the strait with Oman, and Trump earlier this week warned of possible military action against Oman if it interfered with U.S. efforts to reach a deal with Tehran.

Marvell pops, Moderna and Merck soar

Away from the Middle East, there were some notable stock moves on Wall Street on Wednesday.

Shares of Marvell closed almost 10% higher, after the chipmaker said it had inked an expanded partnership with Alphabet’s Google under which it would develop custom silicon programs for the tech behemoth’s AI chips. Notably the agreement also includes a warrant that would allow Google to buy up to nearly 59 million shares of Marvell at $206.58 per share.

Stifel said the deal could represent up to $120 billion in cumulative revenue for Marvell over approximately six-and-a-half years.

Elsewhere, shares of Moderna rocketed about 177% and posted their best day on record, after the vaccine maker along with partner Merck said its mRNA melanoma shot, combined with Keytruda, succeeded in a late-stage trial. Merck added 12.6%, supporting the blue-chip Dow.

Lowe’s trims revenue guidance while Target raises

Looking at earnings-related moves, Lowe’s gained 2.3%, despite cutting its full-year sales guidance, as top boss Marvin Ellison flagged pressure on the home improvement retailer from sluggish spending on large renovation projects.

For internal use only